CLINICAL_TRIALS
trial_result
· 2013-04-04
Clinical Trial Update: EPANOVA in Crohn's Disease, Study 1 [Phase 3]
Summary
This document reports the completion status of a Phase 3 study of EPANOVA for Crohn's disease conducted by Tillotts Pharma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tillotts Pharma AG | Conditions: Crohn's Disease | Phase 3 | Status: COMPLETED